We are live on ! Find out more
CP

Centerbridge Partners Portfolio holdings

AUM $61.1M
1-Year Est. Return 3.67%
This Fund
S&P 500
This Quarter Est. Return
+23.61%
1 Year Est. Return
+3.67%
3 Year Est. Return
+16.09%
5 Year Est. Return
+20.97%
10 Year Est. Return
+25.5%
AUM
$1B
AUM Growth
+$129M
Cap. Flow
-$33.9M
Cap. Flow %
-3.38%
Top 10 Hldgs %
100%
Holding
34
New
2
Increased
1
Reduced
2
Closed
15

Top Buys

Rank Stock Value
1
GOCO
GoHealth
GOCO
+$13M
2
PERF.WS
Perfect Corp Warrants
PERF.WS
+$14.7K

Top Sells

Rank Stock Value
1
GNK icon
Genco Shipping & Trading
GNK
+$28.6M
2
FUN icon
Cedar Fair
FUN
+$20.7M
3
BHC icon
Bausch Health
BHC
+$2.93M
4
VTIQW
VectoIQ Acquisition Corp. II Warrant
VTIQW
+$25K
5
PAQCW
Provident Acquisition Corp. Warrant
PAQCW
+$20K

Sector Composition

Rank Sector Weight
1 Real Estate 22.41%
2 Consumer Discretionary 12.65%
3 Financials 4.35%
4 Industrials 1.1%
5 Technology 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXRAW
26
DELISTED
RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW
– –
-19,999
Closed -$2K
FACA.WS
27
DELISTED
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
– –
-24,999
Closed -$2K
FCAX.WS
28
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
– –
-29,999
Closed -$3K
SHACW
29
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
– –
-50,000
Closed -$2K
VTIQW
30
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
– –
-389,999
Closed -$25K
EQHA.WS
31
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
– –
-24,999
Closed -$3K
CPTK.WS
32
DELISTED
Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CPTK.WS
– –
-33,333
Closed -$2K
PAQCW
33
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
– –
-74,999
Closed -$20K
1
2

Similar funds

KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
HPCM
Hein Park Capital Management New York $61.3M AUM 14.47% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $60.8M AUM 17.47% 1-Year Est. Return
TCDRS
Texas County & District Retirement System Austin, Texas $60.8M AUM 29.03% 1-Year Est. Return
ACM
AREX Capital Management New York $60.5M AUM 45.91% 1-Year Est. Return
CMANY
Capital Management Associates (New York) New York $60.2M AUM 58.47% 1-Year Est. Return
NI
NCP Inc La Quinta, California $60.1M AUM 39.78% 1-Year Est. Return
GC
Greencape Capital Melbourne, Australia $59.9M AUM 23.92% 1-Year Est. Return

Centerbridge Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Centerbridge Partners held 34 positions worth $1B, up 15% from $875M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Centerbridge Partners withdrew a net $33.9M in Q4 2022, closing 15 positions and reducing 2 holdings. Its most notable exit was Bausch Health, an estimated $2.93M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Centerbridge Partners opened a new position in Perfect Corp Warrants worth $11.5K.

  • Centerbridge Partners's largest Q4 2022 buy was Perfect Corp Warrants: 74,999 shares worth $11.5K.
  • Centerbridge Partners added most to GoHealth in Q4 2022, an estimated $13M increase.
  • Centerbridge Partners's biggest Q4 2022 reduction was Genco Shipping & Trading, cutting an estimated $28.6M.
  • Centerbridge Partners fully exited Bausch Health in Q4 2022, selling an estimated $2.93M.
  • Centerbridge Partners's ten largest holdings make up 100% of its $1B portfolio in Q4 2022.
  • Centerbridge Partners opened 2 new positions and closed 15 in Q4 2022.
  • Centerbridge Partners's portfolio value rose 15% quarter-over-quarter to $1B.

Based on Centerbridge Partners's 13F filing for Q4 2022, filed 14 Feb 2023.